Seattle Children's Hospital has had to close operating rooms for the second time this year because of Aspergillus. Better ventilation systems can help.
The presence of the fungus Aspergillus has forced the closing of 11 operating rooms at Seattle Children’s Hospital, marking the second such closure in a year. All 14 of the hospital’s operating rooms will be closed later in the week, said hospital spokeswoman Kathryn Mueller.
"On November 10, routine air test results revealed the presence of Aspergillus in the air in 3 of our operating rooms and 2 procedural areas," Mueller said. "The rooms in which Aspergillus was detected have been closed. We are also investigating 2 new potential Aspergillus surgical site infections."
The hospital has had to postpone some surgeries and move others to different hospitals. Aspergillus is a fungus whose spores are present in the air and can cause illnesses in people with weakened immune systems, damaged lungs, and asthma. Infections caused by Aspergillus include invasive aspergillosis, ABPA CPA, and aspergilloma.
Seattle Children’s Hospital says that the fungus has infected at least 1 patient, and possibly 2. This is the second time the fungus has been discovered in the hospital’s operating rooms. The previous Aspergillus outbreak in May led to at least 5 infections and 1 death.
Hospital officials blame the presence of Aspergillus in the operating rooms on deficiencies in ventilation and purification systems.
An article in HPAC Engineering notes that hospitals consume much more energy than buildings and facilities in other industries of similar size. More energy is therefore needed to ventilate and purify the air.
“Healthcare facilities that may not be properly ventilated, designed, or controlled can lead to the spread of airborne pathogens throughout the facility,” according to the article. “Hospital patients who have compromised immune systems and are more susceptible to infection will likely be infected and can spread pathogens to the rest of the hospital.”
The article, which ran last year, also focused on the importance of a good filtering system in facilities and touts the benefits of bipolar ionization systems. They “create negative and positive ions which then react with oxygen and water vapor within the air stream, creating free radicals. These free radicals in turn create chemical changes, which can damage viruses, bacteria and other microorganisms that often cause infections within a hospital. Even with this kind of system, filter media is still necessary to remove larger particles from the air stream.” A filter media is anything in a filter that changes the quality of what’s being filtered.
The Infectious Diseases Society of America (IDSA) recommends that the response to Aspergillus infection should involve submitting tissue and fluid specimens for histopathologic, cytologic, and culture examination to diagnose invasive aspergillosis. “However, molecular techniques, such as DNA sequencing, should be used to identify Aspergillus species in cases that involve either isolates with atypical growth or concern for resistance,” the IDSA recommends.
A study this year in Antimicrobial Resistance & Infection Control noted that the construction work at hospitals-which seems to be happening more and more-can help breed invasive aspergillosis infection.
Investigators with the University of Ulsan College of Medicine in South Korea, wrote: “Airborne fungal spore levels tended to be higher during the period with heavier construction works involving demolition and excavation, during which the incidence of IA was significantly higher as well.”
They argued that airborne fungal spore levels should be monitored when construction’s taking place in hospitals with patients who have compromised immune systems.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies